These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 630806)

  • 1. Renin, blood volume and response to saralasin in patients on chronic haemodialysis: evidence against volume- and renin-'dependent' hypertension.
    McGrath BP; Ledingham JG
    Clin Sci Mol Med; 1978 Mar; 54(3):305-12. PubMed ID: 630806
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to saralasin and angiotensin's role in essential and renal hypertension.
    Hollenberg NK; Williams GH; Adams DF; Moore T; Brown C; Borucki LJ; Leung F; Bavli S; Solomon HS; Passan D; Dluhy R
    Medicine (Baltimore); 1979 Mar; 58(2):115-27. PubMed ID: 431398
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma catecholamines and the pressor response to Sar1-Ala8-angiotensin II in man.
    McGrath BP; Ledingham JG; Benedict CR
    Clin Sci Mol Med; 1977 Oct; 53(4):341-8. PubMed ID: 913058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of saralasin, an angiotensin II antagonist, on blood pressure and the renin-angiotensin-aldosterone system in normal and hypertensive subjects.
    Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):48-52. PubMed ID: 1071403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II blockade in patients with essential hypertension.
    MacGregor GA; Dawes PM
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):53-4. PubMed ID: 1071404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II and sodium as determinants of the agonistic--antagonistic balance of saralasin's actions.
    Fagard R; Amery A; Lijnen P
    Clin Sci (Lond); 1981 Apr; 60(4):377-85. PubMed ID: 7018793
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of saralasin in hypertensive patients on chronic hemodialysis.
    Lifschitz MD; Kirschenbaum MA; Rosenblatt SG; Gibney R
    Ann Intern Med; 1978 Jan; 88(1):23-7. PubMed ID: 619754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.
    Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
    Prog Biochem Pharmacol; 1976; 12():230-41. PubMed ID: 1019166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaule of renin measurement, saralasin test, and acebutolol treatment in hypertension.
    Kreft C; Menard J; Corvol P
    Kidney Int; 1979 Feb; 15(2):176-83. PubMed ID: 513483
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of 1-sar-8-ala-angiotensin II on arterial pressure, renin and aldosterone in hypertension.
    Fagard R; Lijnen P; Amery A; Reybrouck T
    Contrib Nephrol; 1978; 11():175-8. PubMed ID: 699588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saralasin bolus test. Rapid screening procedure for renin-mediated hypertension.
    Marks LS; Maxwell MH; Kaufman JJ
    Lancet; 1975 Oct; 2(7939):784-7. PubMed ID: 78152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of renin and angiotensin in renovascular hypertension in man.
    Fagard R; Amery A; Billiet L; Joossens JV; Lijnen P; Reybrouck T
    Acta Clin Belg; 1979; 34(3):130-9. PubMed ID: 506622
    [No Abstract]   [Full Text] [Related]  

  • 13. Saralasin in human hypertension: the early experience.
    Brunner HR; Laragh JH
    Kidney Int Suppl; 1979 Mar; (9):S36-43. PubMed ID: 289862
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug interactions with saralasin.
    Mitchell HC; Keeton TK; Pettinger WA
    Kidney Int Suppl; 1979 Mar; (9):S101-6. PubMed ID: 289859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II, plasma renin and sodium depletion as determinants of blood pressure response to saralasin in essential hypertension.
    Thananopavarn C; Golub MS; Eggena P; Barrett JD; Sambhi MP
    Circulation; 1980 May; 61(5):920-4. PubMed ID: 6988103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of angiotensin II blockade by saralasin (1-Sar-8-Ala-angiotensin II) in normal man.
    Ibsen H; Kappelgaard AM; Nielsen MD; Giese J
    Eur J Clin Pharmacol; 1978 Nov; 14(3):171-6. PubMed ID: 729612
    [No Abstract]   [Full Text] [Related]  

  • 17. Angiotensin II blockade in patients with essential hypertension.
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):61-3. PubMed ID: 1071407
    [No Abstract]   [Full Text] [Related]  

  • 18. Angiotensin blockade by saralasin bolus injection.
    Maxwell MH; Marks LS
    Kidney Int Suppl; 1979 Mar; (9):S53-9. PubMed ID: 289864
    [No Abstract]   [Full Text] [Related]  

  • 19. Angiotensin blockade in postoperative paradoxical hypertension of coarctation of the aorta.
    Farrell BG; Parker FB; Poirier RA; Anderson G; Streeten DH; Blackman M
    Surg Forum; 1979; 30():189-90. PubMed ID: 395680
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of the angiotensin II antagonist saralasin on plasma aldosterone concentration and on blood pressure before and during sodium depletion in normal subjects.
    Agabiti-Rosei E; Brown JJ; Brown WC; Fraser R; Trust PM; Lever AF; Morton JJ; Robertson JI
    Clin Endocrinol (Oxf); 1979 Mar; 10(3):227-34. PubMed ID: 455738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.